Dysregulated Metabolism in EGFR-TKI Drug Resistant Non-Small-Cell Lung Cancer: A Systematic Review

Drug resistance is a common barrier to continued effective treatment in cancer. In non-small-cell lung cancer (NSCLC), tyrosine kinase inhibitors that target the epidermal growth factor receptor (EGFR-TKIs) exhibit good efficacy in cancer treatment until acquired resistance occurs. It has been obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Babuta, Julia, Hall, Zoe, Athersuch, Toby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316206/
https://www.ncbi.nlm.nih.gov/pubmed/35888768
http://dx.doi.org/10.3390/metabo12070644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316206/
https://www.ncbi.nlm.nih.gov/pubmed/35888768
http://dx.doi.org/10.3390/metabo12070644

Ejemplares similares